In this study, we aimed to identify novel repositioned drugs and their possible application in P-gp-overexpressing drug-resistant cancer cells; we also assessed the increase in the sensitizing efficacy of repositioned drugs when used as a single treatment at a low dose. This evidence concerns the gene PGP and cancer.